Navigating the New KDIGO Guidelines for Autosomal Dominant Polycystic Kidney Disease

Target Audience

This activity is intended for nephrologists and other healthcare professionals who care for patients with autosomal dominant polycystic kidney disease (ADPKD).

Overview

This Expert Exchange webcast is designed to provide healthcare professionals with an overview of KDIGO's new guidelines for ADPKD that are most relevant/impactful to patient care.

Educational Objectives

Upon completion of this activity, participants should be able to:

• Interpret the updated diagnostic criteria, nomenclature, and risk stratification tools for ADPKD.
• Integrate evidence-based strategies for initiating and managing disease-modifying therapy in patients with ADPKD, with a focus on treatment selection and monitoring.
• Incorporate patient-centered care approaches that emphasize shared decision-making, multidisciplinary collaboration, and structured care pathways to optimize long-term outcomes in ADPKD.

Faculty

Arlene B. Chapman, MD
Professor of Medicine and Section Chief of Nephrology
University of Chicago

Neera K. Dahl, MD, PhD
Professor of Medicine, Division of Nephrology & Hypertension
Director, Mayo Clinic Center of Excellence in Polycystic Kidney Disease
Mayo Clinic

Financial Support

This activity is supported by an independent educational grant from Otsuka America Pharmaceutical, Inc.

Providers

Jointly provided by Medical Education Resources (MER) and Novus Medical Education.

Accreditation Statement

In support of improving patient care, this activity has been planned and implemented by MER and Novus Medical Education. MER is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE) and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Credit Designation for Physicians

MER designates this enduring material for a maximum of 0.5  AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Disclosure of Conflicts of Interest

Medical Education Resources ensures balance, independence, objectivity and scientific rigor in all our educational activities. In accordance with this policy, MER identifies all financial relationships with its instructors, content managers, and other individuals who are in a position to control the content of an activity. Reported relevant financial relationships are mitigated by MER to ensure that all scientific research referred to, reported, or used in a CE activity conforms to the generally accepted standards of experimental design, data collection, and analysis. MER is committed to providing learners with high-quality CE activities that promote improvements or quality in health care and not the business interest of an ineligible company.

The authors/presenters reported the following financial relationships with ineligible companies whose products or services may be mentioned in this activity:

Dr. Chapman
Advisor/consultant: Regulus
Research support: Regulus
Speaker/speakers bureau: Otsuka

Dr. Dahl
Advisor/consultant: Natera, Regulus, Renasant Bio, Vertex
Research support: Natera, Regulus, Vertex

The directors, planners, managers and reviewers of this activity, both for MER and Novus, have no relevant financial relationship(s) to disclose with ineligible companies.

Disclaimer

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications or other courses of diagnosis or treatment discussed in this activity should not be used by clinicians without evaluation of patient conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information and comparison with recommendations of other authorities.

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications. The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications and warnings.

Method of Participation

There are no fees for participating and receiving CME credit for this activity. To claim credit, participants must complete the following:

1. Review the target audience, accreditation information, learning objectives and faculty disclosures.
2. Complete the pre-test (if one exists).
3. View and digest the educational content in its entirety.
4. Complete the post-test and activity evaluation.
5. Physicians who receive a grade of 75% or better on the post-test and complete the evaluation will receive a CME Statement of Credit.
6. All other participants who receive a grade of 80% or better on the post-test and complete the evaluation will receive a Certificate of Participation.

We encourage you to complete the Activity Evaluation to provide feedback for future programming. After submitting the evaluation, you may download the certificate immediately from the confirmation page or afterward by clicking the Download Certificate button in your confirmation email. Records of all CME/CE activities completed can be found on the "My CMEstream" page.    

CME Provider

For additional information about the accreditation of this activity, please contact MER at info@cmepartner.org.

System Requirements

This site requires a computer, tablet or mobile device and a connection to the Internet. For best results, a high-speed Internet connection is recommended. We also recommend using the latest version of your favorite browser to ensure compliance with W3C standards, such as Firefox, Chrome, Safari or Edge.